Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
LAUSANNE, Switzerland and WOBURN, Massachusetts, August 4 /PRNewswire/ --
(Debiopharm), a Swiss-based global biopharmaceutical group
of companies with a focus on the development of prescription drugs that
target unmet medical needs, and Mercury Therapeutics, Inc. (Mercury), a
Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative
SEATTLE, June 24 /PRNewswire-USNewswire/ -- A Commonwealth Fund case study notes that Group
Health Cooperative is structured with incentives aligned "to launch innovations and organize services in ways that make the most sense operationally and clinically."
The case study -- along oth...
Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture
- Objectives Include Interoperability, Collaboration, Clinical Research Advancement -
SAN FRANCISCO, June 4 /PRNewswire/ -- The University of Texas M. D. Anderson Cancer Center, one of the nation's leading centers for cancer care and research, has been instrumental in establishing a Velos A...
New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
NIH Should Fix Standards to Allow Use of Current Stem Cell Lines
SANTA MONICA, Calif., May 20 /PRNewswire-USNewswire/ -- -- Regulations governing stem cell research proposed by the Obama Administration -- unless modified before final implementation on July 1 -- prohibit federal fund...
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
WAYNE, Pa., May 18 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmace...
The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak
SAN DIEGO, April 27 /PRNewswire/ -- The Villa Group
is closely monitoring the recent swine flu outbreak in Mexico and has taken all appropriate steps to ensure the safety and health of all resort guests and employees. None of the Villa Group
resort properties (located in Cabo San Lucas, Puerto Val...
Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
NEW BRUNSWICK, N.J., March 23 /PRNewswire/ -- Each year in the United States more than 138,000 people are diagnosed with leukemia, lymphoma or myeloma. These new cases account for 10 percent of the new total cancer cases in the U.S. per year. For several types of leukemia, the survival rate has ...
InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
WALTHAM, Mass. and NEW YORK, March 20 /PRNewswire/ -- InnoCentive, Inc., the global open innovation marketplace, and Nature Publishing Group
(NPG) , a leading scientific and medical publisher, today announced a partnership to facilitate greater scientific collaboration and open innovation.
New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
EXTON, Pa., Feb. 24 /PRNewswire/ -- BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends(TM): Uloric (R) . Takeda Pharmaceutical Company Limited announced that they received FDA approval for Uloric (R) (generic name: febuxostat) on February 13, 2009. Ul...
Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease
MIAMI, Nov. 12 /PRNewswire/ -- The Miami Jewish Home and Hospital,
Berma Research Group, and Segal Institute for Clinical Research today
announced that they are actively enrolling patients in the CONNECTION
study, a Phase 3 clinical trial that is evaluating the safety and efficacy
of the inves...
Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
Approximately $20 Million of New Business Contracts Announced During the Past Ten Weeks
WAYNE, Penn., Sept. 22 /PRNewswire-FirstCall/ -- Encorium Group, Inc.
(Nasdaq: ENCO ), a full-service multinational contract research organization
(CRO) that provides design, de...
Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
SANTA MONICA, Calif., Sept. 15 /PRNewswire-USNewswire/ -- Gov. Arnold
Schwarzenegger should sign a stem cell public accountability bill, SB1565,
into law, Consumer Watchdog said today. The bill, sponsored by Sen. Sheila
Kuehl and Sen. George Runner, was passed with overwhelming bipartisan
Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
NANJING, China, Sept. 3 /PRNewswire-FirstCall/ -- Simcere
(NYSE: SCR ), a leading manufacturer and supplier of
branded generic pharmaceuticals and manufacturer of the patented
anti-cancer biotech product Endu (also known as Endostar) in China,
announced the interim result...
Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials
- Two Large-Scale Analyses Have Conflicting Results -
CHICAGO, July 28 /PRNewswire-USNewswire/ -- Lack of measureable decline
in memory and thinking processes among placebo groups in Alzheimer's
disease clinical trials might reduce the ability to show the effectiveness
of new Alzheimer thera...
Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
NEW YORK, July 21 /PRNewswire/ -- Ari Kiev, M.D., president of SPRI
Clinical Trials, will be a featured speaker at the upcoming conference Wall
Street Unplugged: The Trout Group
Investor Seminar -- Management's Guide to
Wall Street. The conference will be held on Wednesday, July 30, at Midtown...
The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement
New Partnership under LLS's Therapy Acceleration Program to Advance Development of a Treatment for Acute Myelogenous Leukemia
WHITE PLAINS, N.Y., April 16 /PRNewswire/ -- The Leukemia & Lymphoma
Society (LLS) and Anjin Group, Inc. today jointly announced the execution
of a three-year c...
AcroMetrix Renews Contract With Group Services for America's Blood Centers
BENICIA, Calif., Jan. 22 /PRNewswire/ -- AcroMetrix, a global leader in
quality control materials for molecular and serological diagnostics,
announced today that it will extend its contract with Group
America's Blood Centers (GSABC) through December 31st of 2009. Following
Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment
OAKLAND, Calif., Dec. 20 /PRNewswire/ -- The largest study to examine
the effect of depression on HIV treatment found that depression
significantly worsens a patient's adherence to highly active antiretroviral
therapy and clinical measures, but that effective antidepressant medication
Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
- Pfizer-funded Screening Agreement Fuels Discovery of Novel Compounds, Complements Clinical Development Initiatives with PF-3512676 -
WELLESLEY, Mass., Oct. 30 /PRNewswire-FirstCall/ -- Coley
Pharmaceutical Group, Inc. (Nasdaq: COLY ), a biopharmaceutical company
discovering and developi...
Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
-- CPG 52364, Coley's First Orally-Available, Small Molecule Drug Candidate, Enters Phase I Clinical Development --
WELLESLEY, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Coley
Pharmaceutical Group, Inc. (Nasdaq: COLY ), today announced that it has
dosed its first subject in a Phase...
Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
WELLESLEY, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Coley
Pharmaceutical Group, Inc. (Nasdaq: COLY ), today announced that the company
has received a $3.0 million milestone payment from GlaxoSmithKline (GSK)
associated with the initiation of GSK's Phase III clinical trial in
non-small cell lu...
Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
FALLS CHURCH, Va., Oct. 23 -- Today the National Legal and Policy
Center (NLPC) asked the Inspector General of the United States Agency for
International Development (USAID) to investigate the possibility that the
agency is violating federal law by funding nonprofit groups operating
President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign
Agency's Pro Bono Initiative Aims to Mobilize $25 Million to Eliminate Diseases of Poverty Afflicting the Poorest of the Poor
EAST RUTHERFORD, N.J., Oct. 17 /PRNewswire-USNewswire/ -- MWW Group
(http://www.mww.com ), one of the nation's top ten public relations firms, was
International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
SINGAPORE, Sept. 27 /Xinhua-PRNewswire/ -- NeuroAid(TM) is the first
natural compound to be studied in a large clinical trial focused on stroke
recovery starting in the acute stage. The CHIMES study is a multi-center double-blind placebo-controlled
randomized trial to evaluate the efficacy of...
HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
- Collaborative studies will use HistoRx AQUA(R)-based assays to evaluate
clinical utility of protein biomarkers for predicting treatment response and outcome in brain tumors -
NEW HAVEN, Conn., Sept. 4 /PRNewswire/ -- HistoRx, Inc., announced
today that it has entered int...
Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease
Preliminary Phase II Results Encouraging and Support Phase III Study
DEERFIELD, Ill., Aug. 28 /PRNewswire-FirstCall/ -- Baxter International
Inc. (NYSE: BAX ) and The Alzheimer's Disease Cooperative Study (ADCS) group
today announced the decision to pursue a multi-center U.S. Phase III stud...
American Board of Internal Medicine President Named to Alzheimer's Study Group
PHILADELPHIA, Nov. 29 /PRNewswire-USNewswire/ -- Dr. Christine Cassel,
expert and author on geriatrics and medical issues related to aging, has
been named a member of the Alzheimer's Study Group
(ASG), a new national
task force co-chaired by former Speaker of the House Newt Gingrich and
State of Diabetes in Pittsburgh: Pittsburgh Business Group on
Health Releases Report
Good News: Percentage of Working Age People with Diabetes, Hospital
and Professional Charges Lower Than Both PA and National Averages
PITTSBURGH, April 02, 2007 /PRNewswire-FirstCall/ -- The
Pittsburgh Business Group
on Health (PBGH) announced today the
release of a new report on the prevalence, c...
Malvern initiates European user group meetings for chemical imaging
WORCESTERSHIRE , England, 21 June 2007, Malvern Instruments has
held the inaugural meeting in Europe for users of the company's
near infrared chemical imaging (NIR-CI) systems. The one-day event,
which took place on 13 June 2007 was hosted by AstraZeneca in
Macclesfield, UK. Malvern customers from...
Answerthink and LORENZ Life Sciences Group Announce Strategic
Alliance for the SAP Life Science Industry
MIAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink, Inc. (NASDAQ:
ANSR) announced today that it has formed a strategic alliance with
LORENZ Life Sciences Group
for the distribution of LORENZ solutions
in North America. Answerthink and LORENZ Life Sciences Group
serve midsize companies by integ...
Acuity One-Year Findings Meet All Primary Endpoints in Favor of
Angiomax (Bivalirudin) Alone Treatment Group
Major Bleeding in Patients Treated for Acute Coronary Syndromes
(ACS) Nearly Triples the Risk of Death at One Year
NEW ORLEANS, March 26, 2007 /PRNewswire/ -- One-year findings
from the landmark ACUITY trial show that acute coronary syndrome
(ACS) patients in the "Angiomax(R) (bivalirudin) alone" ...
Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
LYON, France and SWIFTWATER, Pa., Aug. 7 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis group
(EURONEXT: SAN and NYSE: SNY ), announced today the company has submitted to the U.S. Food and Drug Administration (FDA) a supplemental application ...
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
...es therapeutics," said Richard A. Insel, MD, Executive Vice President for Research at JDRF. "The partnership provides JDRF access to a highly talented group
of scientists, state-of-the-art drug discovery technology, and an organization with a proven track record of delivering drugs to the clinic to address...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...mparison, the mean percent change in the Forteo(R) group
for lumbar spine BMD was 5.5 percent, and for femo... months compared with 8.6 percent in the Forteo(R) group
and boosted femoral neck BMD by 4.1 percent compar...re patients enter long-term care, and half of this group
never returns to living independently.
Labopharm files New Drug Submission with Health Canada for novel antidepressant
... baseline to the end of the study in the trazodone group
versus the placebo group. Statistical significance...is showed statistical significance in favor of the group
administered Labopharm's trazodone. In addition, p...t. The drop out rate was 21 percent in the placebo group
and 30 percent in the trazodone group. In the traz...
2,500 Cases Completed With the Magnetic Irrigated Catheter
...nclude a growing number of community hospitals, which are using our advanced technology to build robust electrophysiology practices. With the diverse group
of clinicians who now routinely use our Niobe system, we are particularly delighted that the system has maintained the safety profile for which it has...
ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer
...more than half of the nation's university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group
purchasing organizations, military and government facilities, and major clinics. ARUP is a worldwide leader in innovative laboratory research and deve...
Study Shows Brain Fitness can Save Medicare Billions
...ustment for differences in the groups (or $223 on an unadjusted basis.) The differences between the groups were statistically significant and only the group
using the Posit Science(R) software showed significant savings.
"Our results have important health policy relevance," said Frederic Wolinsky, ...
Scientists Discover Origin of Malaria
...rial Africa, have been identified as the original source of the parasite that likely moved from them to humans via mosquitoes.
An international group
of researchers, including senior author Nathan Wolfe, Ph.D., of the Global Viral Forecasting Initiative and Stanford University, made the discovery, p...
Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
...Idiopathic Neutropenia. Reprints of both publications are available from Telik.
Background on MDS and TELINTRA
MDS is a heterogeneous group
of blood stem cell disorders of increasing incidence. MDS is characterized by ineffective blood cell production involving one or more of the red cell...